NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

The Lilabean Foundation for Pediatric Brain Cancer raises $900K

The Lilabean Foundation for Pediatric Brain Cancer Research raised $900,000 at its 13th Annual Lilabean Foundation Fall Ball, held on Saturday, November 2. Proceeds from the Fall Ball will directly fund groundbreaking research initiatives focused on discovering new treatments and improving survival rates for children fighting pediatric brain cancer.

November 22, 2024

Vol.50 No.44

Clinical Roundup

USC study identifies innate immune system protein as potential target for CRC immunotherapy

Researchers from the USC Norris Comprehensive Cancer Center found evidence that simultaneously targeting the innate and adaptive immune systems holds promise for treating aggressive colon cancer cases. The study has found evidence that targeting CD47, a protein that is part of the innate immune system, could be a key step in fighting colorectal cancer.

November 15, 2024

Vol.50 No.43

In Brief

Cheng-Chia Wu receives St. Baldrick’s grant to support focused ultrasound research for DIPG and DMG

Cheng-Chia “Fred” Wu, assistant professor at Fralin Biomedical Research Institute at Virginia Tech Carilion, received a $115,000 extended scholar grant from St. Baldrick’s to support focused ultrasound research for the treatment of diffuse midline glioma and diffuse intrinsic pontine glioma.

September 13, 2024

Vol.50 No.34

In Brief

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

CureSearch for Children’s Cancer will award $2 million in funding to support a phase I clinical trial in 24 children and young adults with recurrent brain tumors.

September 06, 2024

Vol.50 No.33

Clinical Roundup

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

A study published in Nature reveals the functional relevance of tumor-neuron interactions that regulate the growth of ependymoma brain tumors.

August 02, 2024

Vol.50 No.31

Clinical Roundup

AI system identifies genes that can convert brain cancer cells into functioning immune cells in mice

In an innovative new study of glioblastoma, scientists used artificial intelligence to reprogram cancer cells, converting them into dendritic cells, which can identify cancer cells and direct other immune cells to kill them.

August 02, 2024

Vol.50 No.31

NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

YOU MAY BE INTERESTED IN

The Lilabean Foundation for Pediatric Brain Cancer raises $900K

USC study identifies innate immune system protein as potential target for CRC immunotherapy

Cheng-Chia Wu receives St. Baldrick’s grant to support focused ultrasound research for DIPG and DMG

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

AI system identifies genes that can convert brain cancer cells into functioning immune cells in mice

Renew today!

Subscriber content

Never miss an issue!

Login